Overview

ClearPoint Neuro, Inc. (Nasdaq: CLPT)

Building on the imaging power of MRI, ClearPoint Neuro is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The company's ClearPoint® system, which has received 510(k) clearance and is CE marked, utilizes a hospital's existing MRI suite to enable a range of minimally invasive procedures in the brain. In partnership with Siemens Healthcare, ClearPoint Neuro is developing the ClearTrace® system to enable MRI-guided catheter ablations to treat cardiac arrhythmias, including atrial fibrillation.

Quick Links


Investor Presentations	10-Q

Management Team

Kimble L. Jenkins
Chairman

Joseph M. Burnett
Chief Executive Officer

Peter G. Piferi
Chief Operating Officer

Harold A. Hurwitz
Chief Financial Officer and Secretary

Chris Yelley
Vice President, Operations

Investor Relations

Harold A. Hurwitz
Chief Financial Officer
hhurwitz@clearpointneuro.com

Transfer Agent

Continental Stock Transfer
& Trust Company
One State Street Plaza
30^th Floor
New York, NY 10004-1561

Tel: 212-509-4000
Fax: 212-509-5150

www.continentalstock.com

Auditors

Cherry Bekaert LLP
111 Metropolitan Avenue
Suite 1000
Charlotte, NC 28204

Tel: 704-377-1678

www.cbh.com

SEC Lawyers

Bass, Berry & Sims PLC
The Tower at Peabody Place
100 Peabody Place, Suite 1300
Memphis, TN 38103-3672

Tel: 901-543-5933